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Abstract
Background: It is estimated that 10-15% of all clinically recognised pregnancies result in a
spontaneous abortion or miscarriage. Previous studies have indicated that in up to 50% of first
trimester miscarriages, chromosomal abnormalities can be identified. For several decades
chromosome analysis has been the golden standard to detect these genomic imbalances. A major
drawback of this method is the requirement of short term cultures of fetal cells. In this study we
evaluated the combined use of array CGH and flow cytometry (FCM), for detection of
chromosomal abnormalities, as an alternative for karyotyping.
Methods: In total 100 spontaneous abortions and mors in utero samples were investigated by
karyotyping and array CGH in combination with FCM in order to compare the results for both
methods.
Results: Chromosome analysis revealed 17 abnormal karyotypes whereas array CGH in
combination with FCM identified 26 aberrations due to the increased test success rate. Karyotyping
was unsuccessful in 28% of cases as compared to only two out of hundred samples with
inconclusive results for combined array CGH and FCM analysis.
Conclusion: This study convincingly shows that array CGH analysis for detection of numerical and
segmental imbalances in combination with flow cytometry for detection of ploidy status has a
significant higher detection rate for chromosomal abnormalities as compared to karyotyping of
miscarriages samples.
Background
10 to 15% of all clinically recognised pregnancies end up
in a spontaneous abortion. It is estimated that chromo-
somal abnormalities are the underlying cause in up to
50% of these miscarriages [1,2]. The vast majority of these
chromosomal abnormalities are numerical aberrations
(~86%), including trisomies, monosomies and polyploi-
dies. Other abnormalities are structural aberrations (6%),
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mosomal aberration following meiotic segregation in a
parent having a balanced translocation. In approximately
8% of cases, fetal loss is due to chromosomal mosaicism
in the embryo [3].
Most clinically recognised spontaneous abortions occur
between 7 and 11 weeks of gestation. However, it has
been assumed that most products of conception are lost
even before the pregnancy is clinically recognised as such.
These preclinical losses are due to failure of development,
early arrest in cell division or implantation failure of the
developing embryo.
Although the recurrence risk of numerical imbalances is
very low in case of normal parental karyotypes, cytoge-
netic investigations of miscarriages may be invaluable as
they may eliminate further testing and provide a better
recurrence risk estimate for the couple. Classical cytoge-
netic investigations however, require viable tissue. As a
result, in up to 40% of cases, no reliable karyotype can be
obtained due to a high rate of culture failure. The occur-
rence of maternal contamination and the suboptimal
quality of chromosome preparations are other limiting
factors for chromosome analysis [4-6].
Other genetic techniques have been used to investigate
products of conception, such as fluorescence in situ
hybridization (FISH), multiplex-ligation dependent
probe amplification (MLPA) and quantitative fluorescent
PCR [2,7-9]. Although the majority of chromosomal aber-
rations can be detected with these techniques, structural
aberrations are often missed. By using comparative
genomic hybridization (CGH), numerical and unbal-
anced structural chromosomal aberrations can be identi-
fied without the need of mitotic active cells. However, this
technique is very labour intensive and has a limited reso-
lution [10-15]. Moreover polyploidies, cannot be detected
with this comparative method. This last limitation can be
circumvented by the use of flow cytometry (FCM) [5].
FCM is an easy, rapid, accurate and inexpensive technique
for the measurement of cellular DNA content [16].
Comparative genomic hybridization on DNA-microarrays
(array CGH), or molecular karyotyping, has proven to be
very helpful in the detection of constitutional and
acquired chromosomal aberrations [17-19]. Molecular
karyotyping is fast, does not require tissue culture and
allows screening of the entire genome for imbalances at
high resolution.
In this study, we illustrate the advantages of array CGH
combined with flow cytometry in comparison to conven-
tional karyotyping.
Methods
Samples
Hundred miscarriages and mors in utero samples were
investigated by conventional chromosome analysis, flow
cytometry and molecular karyotyping using ~1 Mb BAC
microarrays. All samples were sent to the Center for Med-
ical Genetics, Ghent University Hospital, Belgium for
chromosome analysis. Ethical approval for this study was
obtained through the Ghent University Hospital ethics
committee. All patients gave consent for molecular
cytogenetic investigations on the miscarriage and mors-
in-utero samples. First trimester miscarriage samples are
generally collected by curettage. The analyses for second
trimester miscarriage and mors in utero samples (obtained
by expulsion of the fetus in toto) were performed on fetal
skin, placental and/or umbilical cord material. The major-
ity of samples were from women with advanced age or
with a history of multiple miscarriages.
Cytogenetic analysis
All tissue samples were grossly examined, removing
maternal blood and decidua. Analysis of G-banded met-
aphase chromosomes was performed on cultured tissue
samples using standard procedures. Karyotypes were
described according to the guidelines of the ISCN 2005.
Flow Cytometry
For DNA content analysis, the Coulter® DNA Prep™ Rea-
gents Kit (Beckman Coulter, Fullerton, CA, USA) was used
according to the manufacturer's recommendations. In
brief, the tissue was passed through a 70 μM Nylon Cell
Strainer filter (Ref: 352350, BD Biosciences (Discovery
Labware, Two Oak Park, Bedford, MA 01730 USA)) to
prepare single cell suspensions. Uncultured cells (5 × 105)
were exposed to DNA Prep LPR for 30 sec, followed by
incubation with DNA Prep Stain for 15 min at room tem-
perature.
The fluorescence was analyzed on a Beckman Coulter
Cytomics FC 500 5-colour flow cytometer equipped with
a 488 nm argon ion laser. Dot plots of the peak area versus
height and the peak ratio (height/area) versus area were
used for doublet discrimination and exclusion. A mini-
mum of 500 events (after exclusion of doublets) was col-
lected.
DNA content analysis included determination of the
mean channel fluorescence and the coefficient of varia-
tion (CV) of the G0/G1 peak. In addition, the DNA-index,
a measure for the degree of DNA content abnormality,
was calculated by dividing the G0/G1 peak channel of the
sample by the G0/G1 peak channel of normal DNA-dip-
loid reference cells obtained from peripheral blood of
healthy volunteers.Page 2 of 5
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DNA was isolated from tissue samples using the QIAamp
DNA Mini Kit (Qiagen), according to the manufacturer's
instructions. Array CGH analysis was performed on an in-
house produced 1 Mb BAC-array as described by Menten
et al. [17]. The scan images were processed with ArrayPro
software (TECAN) and further analyzed with our in-house
developed and freely available software tool arrayCGH-
base http://medgen.ugent.be/arrayCGHbase/[20].
Reporters with a signal to noise ratio < 3 were excluded
from the analysis. Circular Binary Segmentation (CBS)
was used to detect possible chromosomal breakpoints
and calculate an individual chromosome based median.
Results
Conventional cytogenetic analysis
Hundred products of conception were investigated with
conventional cytogenetic analysis using G-banding [see
Additional file 1]. In twenty-eight cases karyotyping was
not possible due to culture failure. Normal karyotypes
were found in 11 (male) and 44 (female) cases. In 17
cases an abnormal karyotype was detected. Chromosomal
abnormalities included predominantly autosomal triso-
mies (n = 9) followed by sex-chromosome aberrations (n
= 2; 45, X) and polyploidy (n = 3; triploid samples). One
apparently balanced and one unbalanced aberration were
identified. The male to female ratio for the samples with a
normal chromosomal result was 0.25, which is suggestive
for maternal contamination due to culture artefacts in
approximately 33% of the investigated samples.
Flow Cytometry
Flow cytometry, utilizing propidium iodide as intercalat-
ing dye, was used to quantify the cellular DNA content of
single cells. Hundred samples were analyzed using this
relatively simple and rapid technique. The results of 3
samples could not be interpreted due to the presence of a
high percentage of apoptotic cells. Ninety-four samples
showed a diploid DNA content whereas 3 samples were
DNA-triploid (DNA-index = 1.45). In the latter 3 samples,
the triploidy was confirmed by karyotyping.
Array CGH
Array CGH was performed on all samples. In 23 cases an
abnormal result was found. Chromosomal abnormalities
included autosomal trisomies (n = 15), monosomy for
the X-chromosome (n = 5) and three structural aberra-
tions (a combined deletion and duplication probably
resulting from an unbalanced translocation and two ter-
minal deletions) (Table 1). Ten of these aberrations were
not detected with conventional karyotyping. One bal-
anced translocation could not be detected by array CGH
but was however inherited from a normal mother and is
therefore probably not causal for the spontaneous abor-
tion.
In two additional cases, a triploidy was suspected due to
aberrant ratios for the sex-chromosomes. Due to poor
DNA quality, no result could be obtained for 2 samples.
In 34 cases a normal male result was obtained. Thirty-nine
samples were of normal female origin giving a male to
female ratio of 0.87.
In Table 2, results of array CGH and FCM are summarized
according to the gestational age (per trimester). From this
table it is clear that highest proportion of chromosomal
aberrations can be found in 1st trimester miscarriages.
In summary, 27 chromosomal abnormalities were identi-
fied in 100 investigated samples by using conventional
karyotyping and array CGH in combination with FCM.
This percentage is rather low compared to previous array
CGH and conventional cytogenetic studies reporting
chromosomal aberrations in up to 50% of spontaneous
abortions [3,21-24]. The proportion of numerical versus
structural chromosomal aberrations is comparable to pre-
vious array CGH based [22,24] and cytogenetic investiga-
tions [3]. Monosomy X was the most common observed
aneuploidy (5) and trisomy 18 and 21 were observed as
the most common trisomies. Other trisomies observed
include chromosome 6, 13, 15 and 16 (Table 1).
Table 1: array CGH and FCM findings in 100 spontaneaous 
abortions/mors in utero samples
finding No of cases
normal male profile 34
normal female profile 38
abnormal profile 26
trisomy 6 2
trisomy 13 1
trisomy 15 2
trisomy 16 2
trisomy 18 4
trisomy 21 4
monosomy X 5
triploidy 3
dup(13)(q32.1qter)del(20)(pterp12.1), male 1
del(7)(q36qter), female 1
del(X)(q28qter), female 1
failure 2
Table 2: array CGH and FCM findings per trimester
trimester§ I
(n = 50)
II
(n = 34)
III
(n = 16)
Total
(n = 100)
normal male 15 17 2 34
normal female 18 11 9 38
abnormal 17 6 3 26
failed 0 0 2 2
aberrant ~34% ~18% ~26%
§: I, II, III: respectively first, second and third trimesterPage 3 of 5
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In order to assess the feasibility of array CGH as an alter-
native to routine karyotyping we compared results
obtained by both methods on a series of 100 samples
from spontaneous abortions. Given the inability of array
CGH to detect triploidy or tetraploidy we decided to com-
plement analyses with flow cytometric assessment of
DNA index. Our results show that array CGH/FCM clearly
outperforms on the standard karyotyping assay. Array
CGH/FCM was successful in almost all samples whereas
karyotype failure was noted in as much as 28% of cases. In
ten cases, array CGH was able to reveal an aberration
whereas the karyotype was normal or failed.
Flow cytometry was able to identify all three triploid sam-
ples identified by conventional karyotyping. Array CGH
showed aberrant ratios for the sex chromosomes for 2 out
of 3 cases. However, the samples could not unambigu-
ously be assigned triploid. Hence, a combined approach
of array CGH and FCM or alternatively quantitative fluo-
rescence PCR, is needed to unambiguously detect poly-
ploidy.
Although this study thus clearly shows the advantages of
array CGH versus karyotyping, other rapid molecular
methods for detection of DNA copy number abnormali-
ties such as fluorescence in situ hybridization (FISH),
multiplex-ligation dependent probe amplification
(MLPA) and quantitative fluorescent PCR could also be of
value for analysing fetal wastage material [2,7-9].
Although the most frequent occurring chromosomal aber-
rations (e.g. trisomy 16, 21, 22) can be detected with these
techniques, certain structural aberrations such as intersti-
tial deletions can however still be missed. Although no
interstitial deletions or duplications were detected in this
study, it can be anticipated that larger follow-up studies
(on higher resolution arrays) might unravel interstitial
aberrations responsible for fetal loss.
One major obstacle in the analysis of abortion material is
avoiding cultural artefact. The present study clearly shows
that karyotyping suffers more from maternal contamina-
tion. We calculated that in ~33% of samples a normal
female karyotype was found due to the presence of mater-
nal tissue.
This percentage is comparable with other reports demon-
strating that at least 30% of 46, XX results are due to con-
tamination by maternal deciduas in first trimester
abortion specimens [4].
With the advent of recent technical innovations, the
increased availability of commercial microarray platforms
and the ability to automate, prices of microarray analysis
are decreasing drastically leading to a price-competitive
platform compared to tissue culture and conventional
karyotyping or other (molecular) cytogenetic techniques
such as MLPA or QF-PCR. The introduction of high reso-
lution oligonucleotide or SNP platforms may eventually
lead to a higher pick-up rate of submicroscopic aberra-
tions responsible for fetal loss.
Conclusion
In conclusion, array CGH analysis for copy number varia-
tions together with FCM for ploidy status determination,
enables a refined and more complete (molecular) cytoge-
netic analysis of spontaneous abortions. Because array
CGH is not dependent on cell culture, reporting times can
be significantly reduced. Furthermore, array CGH/FCM is
less labour intensive and amenable to further automation,
increasing throughput and reducing hands-on time.
Therefore it is likely to become the method of choice in
most clinical diagnostic laboratories, especially since
array CGH has an increased resolution so that smaller
unbalanced chromosomal aberrations can more easily be
detected.
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